ATRX and sarcoma: Intriguingly, Liau and colleagues found that only 20% (3/15) of radiation-associated sarcomas, which can be classified as UPS, or angiosarcoma, or leiomyosarcoma, were ALT+ and none of these tumors showed ATRX loss [68].